| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1468-2982.2004.00641.X |
| P698 | PubMed publication ID | 14687015 |
| P2093 | author name string | W G Ondo | |
| H S Derman | |||
| K D Vuong | |||
| P2860 | cites work | CGRP may play a causative role in migraine | Q28216666 |
| Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study | Q33927756 | ||
| Chronic daily headache | Q33952713 | ||
| Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes | Q34199058 | ||
| Evidence-based medicine: botulinum toxin A in migraine and tension-type headache | Q34253670 | ||
| Classification of daily and near-daily headaches: proposed revisions to the IHS criteria | Q34337439 | ||
| Epidemiology of chronic daily headache | Q34417818 | ||
| Analgesic/abortive overuse and misuse in chronic daily headache | Q34417828 | ||
| Diagnostic issues in chronic daily headache | Q34417835 | ||
| Review of botulinum toxin type A and its clinical applications in migraine headache | Q34515421 | ||
| Sleep bruxism as a motor disorder. | Q34523153 | ||
| Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension | Q34749325 | ||
| Sumatriptan Inhibits Neurogenic Vasodilation of Dural Blood Vessels in the Anaesthetized Rat—Intravital Microscope Studies | Q36869003 | ||
| Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks | Q43576111 | ||
| Prevalence of frequent headache in a population sample | Q46159664 | ||
| Depletion of substance P, neurokinin A and calcitonin gene-related peptide from the contralateral and ipsilateral caudal trigeminal nucleus following unilateral electrical stimulation of the trigeminal ganglion; a possible neurophysiological and neu | Q48908221 | ||
| Psychiatric comorbidity in chronic daily headache. | Q51995489 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | headache | Q86 |
| placebo | Q269829 | ||
| chronic headache | Q2495736 | ||
| P304 | page(s) | 60-65 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Cephalalgia | Q5063251 |
| P1476 | title | Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study | |
| P478 | volume | 24 |
| Q36863514 | Abnormal Tilt Perception During Centrifugation in Patients with Vestibular Migraine |
| Q35996328 | Assessment and management of disability in chronic daily headache |
| Q57024415 | Botulinum Toxin in Headache Treatment: The End of the Road? |
| Q42917912 | Botulinum neurotoxin in the treatment of headache disorders |
| Q37337947 | Botulinum neurotoxins in the treatment of refractory pain |
| Q37722781 | Botulinum toxin in the management of chronic migraine: clinical evidence and experience |
| Q39327986 | Botulinum toxin occipital nerve block for the treatment of severe occipital neuralgia: a case series |
| Q36488226 | Botulinum toxin type A for the treatment of migraine |
| Q51799894 | Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study. |
| Q34112590 | Botulinum toxin type a for chronic migraine |
| Q42653763 | Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study |
| Q39307132 | Botulinum toxin, lidocaine, and dry-needling injections in patients with myofascial pain and headaches |
| Q36259831 | Botulinum toxin: could it be an effective treatment for chronic tension-type headache? |
| Q57689100 | Botulinum toxins for the prevention of migraine in adults |
| Q50547139 | Clinical profile of cluster headaches in Japan: low prevalence of chronic cluster headache, and uncoupling of sense and behaviour of restlessness. |
| Q41650161 | Contribution of intravestibular sensory conflict to motion sickness and dizziness in migraine disorders |
| Q35681903 | Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine |
| Q53407201 | Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action. |
| Q36574510 | Emerging drugs for migraine prophylaxis and treatment. |
| Q38031982 | Emerging treatment for chronic migraine and refractory chronic migraine. |
| Q64086211 | Entrapment Neuropathy: A Concept for Pathogenesis and Treatment of Headaches-A Narrative Review |
| Q36997741 | Evidence based medicine on the use of botulinum toxin for headache disorders |
| Q35697217 | Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A. |
| Q36106970 | Future pharmacologic targets for acute and preventive treatments of migraine |
| Q40387365 | Identification and treatment of cervical and oromandibular dystonia in acutely brain-injured patients |
| Q36600278 | Investigating prophylactic botulinum toxin type A for chronic headache disorders |
| Q83025445 | Is botulinum toxin useful in treating headache? No |
| Q40017256 | Is botulinum toxin useful in treating headache? Yes. |
| Q44029520 | Medication-overuse headache in China: clinical profile, and an evaluation of the ICHD-3 beta diagnostic criteria |
| Q35884231 | Neck pain in chronic whiplash syndrome treated with botulinum toxin. A double-blind, placebo-controlled clinical trial |
| Q37678415 | OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine |
| Q35822040 | OnabotulinumtoxinA for chronic migraine: a critical appraisal. |
| Q38136258 | OnabotulinumtoxinA for the treatment of headache |
| Q36311010 | Pharmacoprophylaxis of tension-type headache |
| Q37418971 | Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache. |
| Q36332480 | The long-term efficacy and safety of botulinum toxin in refractory chronic tension-type headache |
| Q37544903 | The role of botulinum neurotoxin in pain management--an ongoing controversy |
| Q37188687 | Treating headaches with botulinum toxin |
| Q39342164 | Treatment of chronic refractory intractable headache with botulinum toxin type a: a retrospective study |
| Q36419558 | Treatment of headaches with botulinum toxin. |
| Q37940623 | Treatment of refractory pain with botulinum toxins--an evidence-based review |
| Q36359589 | Unlabeled uses of botulinum toxins: a review, part 1. |
| Q37242597 | Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety |
| Q85525623 | [Therapy and care of patients with chronic migraine: expert recommendations of the German Migraine and Headache Society/German Society for Neurology as well as the Austrian Headache Society/Swiss Headache Society] |
Search more.